Cvs Health (CVS) Cost of Revenue (2009 - 2026)

Cvs Health has reported Cost of Revenue for 18 years, with the latest figure at $29.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 0.77% year-over-year to $29.4 billion; the trailing twelve-month figure through Mar 2026 stood at $200.7 billion (up 49.78% YoY), and the FY2025 full-year result was $221.2 billion, up 92.12% from the prior year.
• Cost of Revenue for Q1 2026 stood at $29.4 billion, down from $128.7 billion in the prior quarter.
• The five-year high for Cost of Revenue was $128.7 billion in Q4 2025, with the low at $10.3 billion in Q2 2024.
• Historically, Cost of Revenue has averaged $41.2 billion across 5 years, with a median of $31.3 billion in 2025.
• The largest YoY upside for Cost of Revenue was 213.2% in 2022 against a maximum downside of 85.75% in 2022.
• Cvs Health's Cost of Revenue stood at $18.3 billion in 2022, then surged by 211.73% to $56.9 billion in 2023, then soared by 47.47% to $83.9 billion in 2024, then jumped by 53.33% to $128.7 billion in 2025, then tumbled by 77.19% to $29.4 billion in 2026.
• The last three Cost of Revenue figures came in at $29.4 billion (Q1 2026), $128.7 billion (Q4 2025), and $11.3 billion (Q3 2025), per Business Quant data.